World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 20 March 2023
Main ID:  NCT03070587
Date of registration: 28/02/2017
Prospective Registration: No
Primary sponsor: Komazawa University
Public title: A Pilot Study of Loving-Kindness Meditation for Social Anxiety Disorder
Scientific title: Effect of Mindfulness and Loving Kindness Meditation on Symptoms of Social Anxiety Disorder
Date of first enrolment: December 2016
Target sample size: 52
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03070587
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Investigator).  
Phase:  N/A
Countries of recruitment
Japan
Contacts
Name:     Kohki Arimitsu, Ph.D.
Address: 
Telephone:
Email:
Affiliation:  Kwansei Gakuin University
Key inclusion & exclusion criteria

Inclusion Criteria:

Must be at least 20 years of age Responds positively to the question on the recruitment
material (flyer and posting): "Have you been feeling anxious or distressed in social
situations?" Must be diagnosed with Social Anxiety Disorders using the DSM-5 criteria Must
have SAD as the primary diagnosis according to DSM-5 criteria Must have a negative affect
scale score of the LSAS of at least 30 (a cutoff point which SAD is unlikely)

Exclusion Criteria:

Participants who are at risk of harming themselves will be excluded from participating in
the study. Suicidality will be assessed after obtaining consent during the screening visit.
In addition, the Beck Depression Inventory will be examined for self-reported suidicality.
If a participant is found to have suicidal ideation (i.e., exceed a score of 2 on the
suicide item of BDI-II), the principal investigator will be contacted immediately and
appropriate follow-up care will be provided by referring the participant to the emergency
room.

Participants will be assessed through a screening interview using the Structured Clinical
Interview for DSM-5 for disorders that could impose a safety risk for the participants or
others (e.g., bipolar disorder, schizophrenia, etc). Subjects who endorse "yes" responses
to the screening items will be excluded.

Participants who are receiving any psychiatric or psychological treatment for any
psychological disorders at the time of the assessment will be excluded from the study.
Participants who initiate such treatments while being enrolled in the study will be closely
monitored. These participants will be allowed to remain in the study, but will later be
excluded from the data analyses. They are allowed to remain in the study for ethical
reasons.



Age minimum: 20 Years
Age maximum: 70 Years
Gender: All
Health Condition(s) or Problem(s) studied
Social Anxiety Disorder
Compassion
Intervention(s)
Behavioral: Positive Affect Training for SAD
Primary Outcome(s)
Change from Baseline in the Liebowitz Social Anxiety Scale (LSAS) [Time Frame: Baseline and 6 months]
Secondary Outcome(s)
Change from Baseline in compassion subscale of Differential Positive Emotions Scale [Time Frame: Baseline and 6 months]
Change from Baseline in Self-Compassion Scale (SCS) [Time Frame: Baseline and 6 months]
Change from Baseline in Positive and Negative Affect Scale (PANAS) [Time Frame: Baseline and 6 months]
Secondary ID(s)
001
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history